Genome-wide capture sequencing to detect hepatitis C virus at the end of antiviral therapy

by Peng Peng, Yanjuan Xu, Michael W. Fried, Adrian M. Di Bisceglie, Xiaofeng Fan
Published 2020-08-01

Development and pilot-testing of a cognitive behavioral coping skills group intervention for patients with chronic hepatitis C

by Donna M. Evon, Ph.D., Carol E. Golin, Rachel Ruffin, Michael W. Fried
Published 2017-06-01

Novel patient-reported outcomes (PROs) used in a pilot and feasibility study of a Cognitive Behavioral Coping Skills (CBCS) group intervention for patients with chronic hepatitis C

by Donna M. Evon, Carol E. Golin, Rachel Ruffin, Shauna Ayres, Michael W. Fried
Published 2018-06-01

Deep sequencing analysis of HCV NS3 resistance-associated variants and mutation linkage in liver transplant recipients.

by Mariana E Kirst, Eric C Li, Cindy X Wang, Hui-Jia Dong, Chen Liu, Michael W Fried, David R Nelson, Gary P Wang
Published 2013-01-01

Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

by Victor J Navarro, Steven H Belle, Massimo D'Amato, Nezam Adfhal, Elizabeth M Brunt, Michael W Fried, K Rajender Reddy, Abdus S Wahed, Stephen Harrison, Silymarin in NASH and C Hepatitis (SyNCH) Study Group
Published 2019-01-01

Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.

by Victor J Navarro, Steven H Belle, Massimo D'Amato, Nezam Afdhal, Elizabeth M Brunt, Michael W Fried, K Rajender Reddy, Abdus S Wahed, Stephen Harrison, Silymarin in NASH and C Hepatitis (SyNCH) Study Group
Published 2019-01-01

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis

by Kavita Radhakrishnan, Adrian M. Di Bisceglie, K. Rajender Reddy, Joseph K. Lim, Josh Levitsky, Mohamed A. Hassan, Jama M. Darling, Jordan J. Feld, Lucy Akushevich, Monika Vainorius, David R. Nelson, Michael W. Fried, Robert S. Brown Jr., Norah A. Terrault
Published 2019-10-01

A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic h...

by Donna M Evon, Paul W Stewart, Jipcy Amador, Marina Serper, Anna S Lok, Richard K Sterling, Souvik Sarkar, Carol E Golin, Bryce B Reeve, David R Nelson, Nancy Reau, Joseph K Lim, K Rajender Reddy, Adrian M Di Bisceglie, Michael W Fried
Published 2018-01-01

P49 MAGELLAN-1, PART 2: glecaprevir and pibrentasvir for 12 or 16 weeks in patients with chronic HCV genotype 1 or 4 and prior direct-acting antiviral treatment failure

by Fred Poordad, Stanislas Pol, Armen Asatryan, Maria Buti, David Shaw, Christophe Hézode, Franco Felizarta, Robert W. Reindollar, Stuart C. Gordon, Stephen Pianko, Michael W. Fried, David E. Bernstein, Joel Gallant, Chih-Wei Lin, Yang Lei, Teresa I. Ng, Tami Pilot-Matias, Jens Kort, Federico Mensa
Published 2017-08-01